Yang_2024_BMC.Musculoskelet.Disord_25_661

Reference

Title : Two PNPLA2 heterozygous mutations result in neutral lipid storage disease with myopathy: a case report - Yang_2024_BMC.Musculoskelet.Disord_25_661
Author(s) : Yang T , Zhu J , Kang Y , Tang C , Zhang L , Guo L
Ref : BMC Musculoskelet Disord , 25 :661 , 2024
Abstract :

BACKGROUND: Neutral Lipid Storage Disease with Myopathy (NLSDM) is a rare lipid metabolism disorder caused by PNPLA2 gene mutations. Clinical manifestations are heterogeneous, and diagnosis is often delayed, usually gaining patients' attention due to the increased risk of cardiomyopathy. CASE PRESENTATION: We herein report a 36-year-old Asian male presenting with progressive limb weakness, muscle atrophy of limbs and trunk, dysarthria, and heart failure. Electromyography indicated myogenic changes, and muscle biopsy results revealed characteristics of lipid storage myopathy. Genetic analysis of PNPLA2 revealed two heterozygous mutations: c.757 + 1G > T (chr11-823588, splice-5) on intron 6 and c.919delG (chr11-823854, p.A307Pfs*13) on exon 7. The patient improved limb strength, and dysarthria disappeared after the Medium Chain Fatty Acids diet. CONCLUSIONS: In conclusion, we report for the first time that the two heterozygous mutations PNPLA2 c.919delG and c.757 + 1G > T together induced NLSDM, which was confirmed by muscle biopsy.

PubMedSearch : Yang_2024_BMC.Musculoskelet.Disord_25_661
PubMedID: 39174932

Related information

Citations formats

Yang T, Zhu J, Kang Y, Tang C, Zhang L, Guo L (2024)
Two PNPLA2 heterozygous mutations result in neutral lipid storage disease with myopathy: a case report
BMC Musculoskelet Disord 25 :661

Yang T, Zhu J, Kang Y, Tang C, Zhang L, Guo L (2024)
BMC Musculoskelet Disord 25 :661